Prophylaxis of fetoplacental insuffiency in the 1 trimester of pregnancy
- Authors: Bashmakova N.V.1, Sevastyanova O.J.1, Mitseva S.B.1
-
Affiliations:
- Urals Institute of Maternity and Childhood Care
- Issue: Vol 48, No 5S (1999)
- Pages: 41-41
- Section: Articles
- URL: https://journals.eco-vector.com/jowd/article/view/100801
- DOI: https://doi.org/10.17816/JOWD100801
- ID: 100801
Cite item
Full Text
Abstract
It is known that permanent threatening abortion in the 1 trimester is the reason of early fetoplacental insufficiency and fetal intrauterine growth retardation.
Aim: To evaluate the possibility of dydrohesterone use for prophylaxis of fetoplacental insufficiency in women with the history of habitual abortion.
Full Text
It is known that permanent threatening abortion in the 1 trimester is the reason of early fetoplacental insufficiency and fetal intrauterine growth retardation.
Aim: To evaluate the possibility of dydrohesterone use for prophylaxis of fetoplacental insufficiency in women with the history of habitual abortion.
Methods: Clinical, hormonal, histological, ultrasound and doppler examination, mathematical analysis.
Object: 32 women in the 1 trimester of pregnancy, from the risk groups for miscarriage.
Results: Decreased concentrations of fetoplacental complex hormones were registered in 40,6% of women without signs of threatened abortion. In other cases, symptoms of permanent threatened abortion were diagnosed. Markers of urogenital infection were revealed in 46,9%.
Treatment of threatened abortion and hormonal disbalance correction with dydrohesterone were held according to standard scheme together with symptomatic therapy. Pregnancy progressed in 91% of cases. Normal hormonal status was shown in 77,7% of women and symptoms of threatened abortion disappeared in 90,6% of cases. Fetoplacental insufficiency was not diagnosed or was compensated in 90,7% of women.
Conclusion: Use of dydrohesterone in complex therapy of threatened abortion in 1 trimester helps to end the threat of abortion, to normalize hormonal status and it is effective in the prophylaxis of primary fetoplacental insufficiency.
About the authors
N. V. Bashmakova
Urals Institute of Maternity and Childhood Care
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Ekaterinburg
O. Ju. Sevastyanova
Urals Institute of Maternity and Childhood Care
Email: info@eco-vector.com
Russian Federation, Ekaterinburg
S. B. Mitseva
Urals Institute of Maternity and Childhood Care
Email: info@eco-vector.com
Russian Federation, Ekaterinburg